In: Accounting
Revenue |
216,000 |
|
Cost of sales |
91,080 |
|
Distribution costs |
21,180 |
|
Administrative expenses |
23,760 |
|
Interest paid |
2,880 |
|
Income tax |
1,800 |
|
Property, plant and equipment: |
||
Carrying amount at 1 November 20X7 |
270,000 |
|
Inventories – 31 October 20X8 |
18,000 |
|
Trade receivables |
22,500 |
|
Bank |
10,800 |
|
Payables |
11,880 |
|
Deferred tax – 1 November 20X7 |
12,600 |
|
8% Loan note – issued 1 November 20X7, repayable 20Y2 |
72,000 |
|
Ordinary $1 share capital |
45,000 |
|
Retained earnings – 1 November 20X7 |
100,920 |
|
460, 200 |
460,200 |
(i) Revenue includes cash sales of £6 million for goods sold in August 20X8 to Abbeyfax plc, a bank. The goods are marked up at 25% on cost. Abbeyfax has the option to require Nemesis Ltd to repurchase these goods on 1 November 20X8 at their original selling price plus a one-off fee of £180,000. Abbeyfax has not taken delivery of the goods, and has always made Nemesis repurchase goods in the past under similar agreements.
(ii) Included within property, plant and equipment is a building with a carrying amount of £4.5 million. On 1 November 20X7 it was revalued to $6 million. The building had an estimated life of twenty five years when purchased ten years prior to the revaluation date. This has not changed as a result of the revaluation. The directors of Nemesis Ltd wish to incorporate this value into the financial statements for the year ended 31 October 20X8.
All other property, plant and equipment is depreciated at 20% per annum on the reducing balance basis.
(iii) On 1 October 20X8, Nemesis closed down its Merry Go Round division. The results of
the division from 1 November 20X7 to the date of closure are included in the above trial balance figures. These results are as follows:
$000
Revenue 9,800
Cost of sales 6,450
Distribution costs 2,040
Admin expenses 1,980
The net assets of the division were sold at a loss of $3.2 million which is currently included
within cost of sales. The Merry Go Round division satisfies the criteria for a discontinued
operation under IFRS5 Non-current Assets Held for Sale and Discontinued Operations.
(iv) The provision for income tax for the year ended 31 October 20X8 has been estimated at $23.4 million. The only temporary differences for deferred taxation purposes are in respect of accelerated capital allowances, which at 31 October 20X8 were $43.2 million. Income tax is charged at 20%.
(v) The company has a share option scheme in operation. The terms of the options are that option holders are permitted to subscribe for 1 equity share for every option held at a price of £2 per share. At 1 November 20X7, 20 million share options were in issue. On 1 May 20X8, the holders of 10 million options exercised their option to purchase, and 14 million new options were issued on the same terms as the existing options. During the year ended 31 October 20X8, the average market price of an equity shares in Nemesis Ltd was £4.00.
Required:
Prepare a statement of profit or loss and other comprehensive income for the year ended
31 October 20X8 for Nemesis together with a statement of financial position and a statement of changes in equity at that date.
Statement of profit or loss and other comprehensive income for Nemesis for the year ended 31 October 20X8
$000
Continuing operations
Sales Revenue (216,000 – 12,000 ( from W1) – 9,800 ( from W3)) 194,200
COS (W2) (124,830)
–––––––Gross profit 69,370
Distribution costs (21,180 – 2,040 (W3)) (19,140)
Administration expenses (23,760 – 1,980 (W3)) (21,780)
–––––––Profit from operations 28,450
Financecosts:Accrued interest Abbeyfax (W1) (360)
Loan note interest (72,000 × 8%) (5,760)
Investment income (4,680 + 1,350 (W4)) 6,030
–––––––
Profit before tax 28,360Tax (W5) (15,480)
Profit for year from continuing operations 12,880
Discontinuing operations
Loss on discontinuing operation (W3) (3,870)
–––––––
Total profit for the year 9,010
Other comprehensive Income
Revaluation gain (W7) 3,000 –––––––Total comprehensive income 12,010 –––
Statement of financial position for Nemesis as at 31 October 20X8
$000 $000
Non-current assets
Property, Plant and Equipment (W7) 220,000
Investment Property (W4) 46,350 –––––––
266350
Current assets
Inventory (18,000 + 9,600 (W1)) 27,600
Trade receivables 22,500
Bank 10,800
60,900
–––––––
327,250
Equity
Share capital 90,000Retained earnings(SOCIE) 109930 Revaluation(SOCIE) 3000
302930
Non-current liabilities
8% Loan note 72,000
Deferred tax (W6) 6,480
78,480
Current liabilities
Loan from Abbeyfax (W1) 12,000
Accrued interest on sale and repurchase loan (W1) 360
Tax payable 23,400
Loan interest accrual (5,760(payable) – 2,880(paid)) 2,880
Trade payables 7,200
––––––
45,840
–––––––
327,250
–––––––
Statement of changes in equity for Nemesis for the year ended 31 October 20X8
Sharecapital Retainedearnings RevaluationReserve Total
Bal at 1 November 20X7 90,000 100,920 – 190,920
Profit for year(perstatement of
profit or loss) 9,010 9,010
Revaluation gain (W7) 3,000 3,000
–––––– ––––––– ––––– –––––––
Bal at 31 October 20X8 90,000 109,930 3,000 209,930
–––––– ––––––– ––––– –––––––